Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Procysbi“
Suchtreffer
Begriffe & Kennungen
Procysbi
Eintrag öffnenProcysbi · 4.1 Therapeutic indications · 1
Eintrag öffnenProcysbi · 4.3 Contraindications · 1
Eintrag öffnenProcysbi · 4.3 · • Hypersensitivity to the active substance, any form of cysteamine (mercaptamine), or to any of the excipients
Eintrag öffnenProcysbi · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenProcysbi · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenProcysbi · 4.5 · Co-administration of the proton pump inhibitor omeprazole and PROCYSBI in vivo showed no effects on cysteamine
Eintrag öffnenProcysbi · 4.5 · Co-administration with electrolyte and mineral replacement
Eintrag öffnenProcysbi · 4.5 · Cysteamine can be administered with electrolyte (except bicarbonate) and mineral replacements necessary for ma
Eintrag öffnenProcysbi · 4.5 · Indomethacin and cysteamine have been used simultaneously in some patients. In cases of patients with kidney t
Eintrag öffnenProcysbi · 4.5 · It cannot be excluded that cysteamine is a clinically relevant inducer of CYP enzymes, inhibitor of P-gp and B
Eintrag öffnenProcysbi · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenProcysbi · 4.8 Undesirable effects · 1
Eintrag öffnenProcysbi · 4.8 · 7 nervous system disorders (headache, somnolence and lethargy) and common general disorders (asthenia) were al
Eintrag öffnenProcysbi · 4.8 · A few cases of Ehlers-Danlos-like syndrome on elbows have been reported in children chronically treated with h
Eintrag öffnenProcysbi · 4.8 · Blood and lymphatic system disorders Uncommon: Leukopenia Immune system disorders Uncommon: Anaphylactic react
Eintrag öffnenProcysbi · 4.8 · Clinical studies experience with PROCYSBI In clinical studies comparing PROCYSBI to the immediate-release cyst
Eintrag öffnenProcysbi · 4.8 · Description of selected adverse reactions
Eintrag öffnenProcysbi · 4.8 · For the immediate-release formulation of cysteamine bitartrate, approximately 35% of patients can be expected
Eintrag öffnenProcysbi · 4.8 · Post-marketing experience with immediate-release cysteamine bitartrate Benign intracranial hypertension (or ps
Eintrag öffnen